Assisted reproductive technology

Size: px
Start display at page:

Download "Assisted reproductive technology"

Transcription

1 Assisted reproductive technology FERTILITY AND STERILITY Vol. 60, No.2, August 1993 Copyright 'c; 199:~ The American Fertility Society Printed on acid-free paper in U. S. A. Natural cycle in vitro fertilization-embryo transfer at the University of Ottawa: an inefficient therapy for tubal infertility* Paul Claman, M.D. t Minerva Domingo, M.D. Peter Garner, M.D. Arthur Leader, M.D. John E. H. Spence, M.D. Goal Program, Department of Obstetrics and Gynecology, Ottawa Civic Hospital, Uaiversity of Ottawa, Ottawa, Ontario, Canada Objective: To describe our experience with natural cycle IVF making clinical and endocrine comparisons with our standard stimulated cycle IVF program. Design: We attempted 75 natural IVF-ET cycles with hcg given to preempt the LH surge and compared these with 450 attempts at standard superovulation IVF -ET done in our unit during the same time period. Patients: Natural cycle patients are normally ovulating women < age 38. Superovulation IVF ET patients are all <41 years old. Patients in both groups had partners with normal semen parameters and tubal factor infertility. Main Outcome Measures: Cancellation rates, pregnancy rates per egg retrieval, per ET procedure, and luteal phase E 2 :P ratios of the treatment cycles are compared. Results: There were 35 of 75 (47%) natural cycle and 112 of 450 (25%) superovulation cycle cancellations. An egg was retrieved in only 24 of 40 (60%) natural cycles and 336 of 338 (99%) superovulation egg retrieval procedures. Pregnancy rates per ovum pick-up procedure were significantly higher: 65 of 338 (19%) in the superovulation versus 2 of 40 (5%) in the natural cycle groups. Pregnancy rates per ET were not significantly different between natural IVF -ET, 2 of 18 (11 %) and superovulation IVF-ET, 65 of 298 (22%). The E 2 :P ratios 5 days after ET were similar in both groups at 18 ± 4 after natural IVF-ET and 21 ± 18 after superovulation IVF-ET. Conclusions: [1] Cancellation rates for natural cycle IVF are very high. [2] Midluteal E 2 :P ratios are the same in both groups. [3] Pregnancy rates per egg retrieval are significantly lower for natural versus superovulation IVF-ET. [4] In our experience, natural cycle IVF-ET is an inefficient therapy for tubal infertility compared with superovulation IVF-ET. Fertil Steril 1993;60: Key Words: In vitro fertilization, embryo transfer, natural cycle, unstimulated cycle The first successful pregnancy after human IVF - ET was done by retrieving an oocyte during an unstimulated natural menstrual cycle (1). With refinements in controlled ovarian stimulation, natural Received January 22, 1993; revised and accepted April 19, * Presented at the 48th Annual Meeting of The American Fertility Society, New Orleans Louisiana, November 2 to 5, t Reprint requests: Paul Claman, M.D., 737 Parkdale Avenue, Ottawa, Ontario, Canada K1 Y 4E9. cycle IVF was abandoned in the early 1980s in favor of superovulation IVF leading to higher pregnancy rates (PRs) per egg retrieval procedure than could be achieved in the natural cycle (2). In recent years, the technological advances of ultrasound (US) guided egg retrieval replacing laparoscopy and a better understanding of the LH surge to ovulation interval (3) have rekindled interest in the use of unstimulated cycles for IVF -ET in the treatment of infertility (4-7). We attempted 75 natural cycle IVF -ET cycles and compared these with 450 superovulation cycle attempts at IVF -ET done during 298 Claman et al. Natural cycle versus superovulation IVF-ET Fertility and Sterility

2 the same time frame under the same laboratory conditions. MATERIALS AND METHODS Seventy-five natural cycle IVF-ET cycles were studied and compared with 450 superovulation IVF -ET cycles. Both groups of patients had tubal factor infertility with normal semen parameters (8). Patients with tubal factor infertility were offered natural cycle IVF-ET as an option to a standard IVF-ET superovulation protocol, but allocation was not randomized. Inclusion criteria for the natural cycle protocol include the following: age < 38, normal ovulatory function (regular cycles, normal BBT chart, and in-phase late luteal timed endometrial biopsy), serum FSH <10 on cycle days 3 to 5, and both ovaries accessible to transvaginal US-guided egg retrieval. Inclusion criteria in the superovulation IVF-ET-treated patients were age < 41 years in addition to the criteria noted above. The natural cycle protocol involved drawing a baseline serum LH before cycle day 9 and monitoring daily serum LH, E2, and US starting on cycle day 10. Human chorionic gonadotropin (Profasi; Serono Canada, Mississauga, Ontario, Canada) 2,500 IU 1M (30 cases) or 5,000 IU 1M (10 cases) was given 34 hours (35 cases) or 36 hours (5 cases) before ovum pick-up when a follicle> 18 mm diameter was seen on US in association with an E2 > 180 pg/ml (650 pmol/l). Cycles were canceled if LH levels were found to be more than two times the baseline value or if E2 levels fell during monitoring. Egg retrieval was done by transvaginal guided US. Analgesia at ovum pick-up included 50 to 200 Ilg IV fentanyl and in some cases medazolam 1 mg. Lidocaine, 0.5%, was injected into the vaginal mucosa of the lateral vaginal fornices after preparing the vagina with a normal saline rinse. Patients received cefazolin, 1 g IV, before ovum pick-up. Standard superovulation protocol used leuprolide acetate (Lupron; Abbott Pharmaceuticals, Montreal, Quebec, Canada) in the midluteal phase before hmg therapy as previously described (9). Fertilization with Percoll-treated sperm (10) and ET of a maximum of four embryos was performed in the same way for both superovulation and natural cycle IVF-ET. Luteal phase support using hcg 1,500 IU 1M every 3 days for three doses starting 1 day after ovum pick-up was given in both natural cycle and superovulation IVF -ET cycle patients. Progesterone luteal support was used in superovulation cycles when E2 was >2,700 pg/ml (10,000 pmol/l) at the time of the preovum pick-up hcg 5,000 IU ovulation trigger. Progesterone in oil (Steris Labs, Phoenix, AZ) 12.5 mg/d 1M was given starting on the day after the hcg trigger. On the day of ET, the P dosage was increased to 25 mg/d. If pregnant, P was continued until fetal heart activity was seen on US. Serum E2 and P were drawn 5 days after ET in both natural and superovulation IVF -ET treatment cycles. Endocrine tests (E2, P, FSH, LH, and (3-hCG) were all done in serum using commercial RIA kits (FSH, LH, and (3-HCG by Amerlex-M, Amersham Canada Ltd, Ontario, Canada and E2 by Pantex, Santa Monica, CA). Estradiol was assayed on the day of hcg trigger, day of ET, and 9 days after the hcg trigger (i.e., midluteal phase). Progesterone was assayed on the day of ET and 9 days after the hcg trigger. Pregnancy testing with a serum (3- hcg assay was done 17 days after ET. Pregnancy is defined by the identification of a gestational sac on US done at least 4 weeks after ET. A two-tailed Student's t-test was used to compare endocrine data after testing for normality, and x2 or Fisher's exact test was used where appropriate. RESULTS There were 35 of 75 (47%) natural cycle and 112 of 450 (25%) superovulation cycle cancellations (P < ) (Table 1). An egg was retrieved at ovum pick -up in only 24 of 40 (60%) natural cycles and in 336 of 338 (99%) superovulation ovum pick-up procedures (P < ). Of those ovum pick-ups producing at least one egg, there was a trend to having a better chance of at least one embryo being available for transfer in the superovulation IVF cycles with 18 of 24 (60%) natural IVF -ET and 298 of 336 (89%) superovulation cases, resulting in at least one embryo for transfer (P = 0.098). Pregnancy rates per cycle initiated were much higher in the superovulation 65 of 450 (14.4%) versus the natural cycle cases 2 of 75 (2.7%) P = Pregnancy rates per ovum pick-up were also significantly higher in the superovulation 65 of 338 (19%) versus 2 of 40 (5%) in the natural cycle groups (P = 0.044). Pregnancy rate per ET procedure appear similar in both groups with 2 of 18 (11 %) pregnant after natural IVF -ET and 65 of 298 (22%) after superovulation IVF-ET (P = 0.434). Miscarriage or ectopic pregnancies appear similar in both groups, with pregnancies going to term in 48 of 65 (74%) superovulation and 2 of 2 natural IVF-ET Vol. 60, No.2, August 1993 Claman et al. Natural cycle versus superovulation IVF-ET 299

3 Table 1 Results of Natural Cycle IVF-ET Versus Superovulation IVF-ET Nautral cycle IVF-ET Superovulation IVF-ET Probability No. cycles started No. of cancellations ;:,:1 egg found per ovum pick-up procedure ;:,:1 cleaving embryo per ovum pick-up if egg retrieved Pregnancies per ET procedure Pregnancies per ovum pick-up procedure Term pregnancies per ovum pick-up procedure Pregnancies per cycle started E 2 :P ratio 5 days after ovum pick-up* (47)* 24/40 (60) 18/24 (60) 2/18 (11) 2/40 (5) 2/40 (5) 2/75 (2.7) 18 ± (25) 336/338 (99) 298/336 (89) 65/298 (22) 65/338 (19) 48/338 (14) 65/450 (14.4) 21 ± 18 < < NSt NSt * Values in parentheses are percents. t NS, not significant. :j: Values are means ± SD. pregnancies (P = 0_99). There were 13 of 65 (20%) multiple pregnancies (8 twins, 4 triplets, and 1 quadruplet) in the superovulation IVF-ET group. Both pregnancies from natural cycle IVF-ET were singleton. The E2:P ratio 5 days after ET was similar in both groups at 18 ± 4 after natural IVF-ET and 21 ± 18 (n = 67) after superovulation IVF -ET (P = 0.556). Furthermore, the E2:P ratio 5 days after ET was not statistically different between natural IVF -ET 18 ± 4 or superovulation IVF -ET whether hcg (n = 39) 17 ± 8 (P = 0.7) or P (n = 28) 28 ± 25 (P = 0.227) was used for luteal support. Baseline LH:FSH ratios in natural cycle IVF -ET did not help predict which patients would be canceled with LH:FSH = ± in canceled versus ± in noncanceled cases (P = 0.6). The baseline LH:FSH of ± in patients canceled because of a premature LH surge was not significantly different from ± in nonsurgers. The E2 on the day of hcg trigger was the same whether an egg was (234 ± 67 pg/ml [858 ± 245 pmol/ml» or was not (241 ± 74 pg/ml [886 ± 272 pmol/ml» retrieved at ovum pick-up in the natural IVF -ET group. DISCUSSION The first successful IVF -ET trials used laparoscopic oocyte retrieval timed to the LH surge in unstimulated cycles. Forty-four oocytes were retrieved in 68 laparoscopic procedures. Because only 65 % of laparoscopic procedures led to successful retrieval of an egg and 68% of these eggs fertilized and cleaved for transfer (1), efforts at improving the success of IVF -ET concentrated on developing protocols for stimulating multiple follicular development (2). The importance of ensuring the availability of mature oocytes after an egg retrieval procedure was especially compelling in an era when laparoscopy and general anesthesia were needed for follicle aspiration. However, availability of minimally invasive methods for follicle aspiration (11) and a better understanding of LH surge physiology (3) have led to renewed interest in performing IVF ET in natural cycles. The potential advantages of natural cycle IVF ET are as follows. First, the costs to patient and facility are lower because only hcg is given and the amount of hormone and US monitoring needed is halved. Second, without hmg stimulation, the risks of ovarian hyperstimulation syndrome and multiple pregnancy are obviated. Third, the emotional "roller coaster" of IVF -ET is minimized by removing the almost obsessive daily concerns surrounding the ovarian response to hmg. Fourth, with maintenance of physiological steroid hormone concentrations found in the natural cycle, there may be a higher PR per transferred embryo. Although some centers have attempted natural cycle IVF -ET timed to the endogenous LH surge (5, 7), we and others (4, 6) chose to preempt the endogenous LH surge with hcg to ensure adequate time between LH-like stimulation and ovum pick-up (3) and to prevent the need to perform ovum pick-up procedures in late afternoon or early evening hours, which are impractical in our clinic setting. Although monitoring for natural cycle IVF-ET is much less intensive than during the protocol for superovulation IVF -ET, the cancellation rate of 47% was believed to be unacceptable in the natural IVF -ET cycle protocol, despite careful attention to excluding women with ovulatory dysfunction. Most cancellations occurred because of the endogenous LH surge despite choosing a low morning value E2 of >180 pg/ml (650 pmol/l) to indicate a later hcg injection (given at 10:00 to 11:00 P.M.). The 47% cancellation rate was significantly higher than 300 Claman et ai. Natural cycle versus superovulation IVF-ET Fertility and Sterility

4 the 25% cancellation rate in the superovulation protocol despite the fact that recent hmg protocol adjustments have been made to reduce an unacceptably high cancellation rate for superovulation IVF-ET employing GnRH analogue down regulation with hmg administration (12). Although transvaginal US-guided follicle aspiration is less traumatic than laparoscopy, it is not without risk of infection or bleeding and does involve intensive preparation with the presence of physician, nursing, and laboratory personnel as well as culture media preparation. In this experience with natural cycles, successful aspiration of the dominant follicle with a 3- to 4-mL aspirate was almost always achieved, but egg retrieval was only successful in 60% of these ovum pick-up procedures, despite multiple attempts at flushing. This is compared with a 99% chance of retrieving at least one egg in a superovulation cycle. This low success rate for retrieving the egg in unstimulated cycles is similar to those originally reported by laparoscopy (1) but lower than the 98% (4) and> 100% (1.6 eggs per aspiration) (6) reported by others using a similar protocol with hcg preempting the LH surge in natural cycles. Of those groups reporting the use of the endogenous LH surge alone in unstimulated cycles, oocytes were obtained in 88% to 100% of cycles (5, 7). The only explanation for the lower 60% successful egg retrieval rate in this series, compared with that reported by others, is possibly the policy of canceling cases with an endogenous LH surge. Canceling LH surge cycles was also the reported protocol at the University of Southern California (6). Operator inexperience is an unlikely problem, noting that we have performed five to eight transvaginal US-guided ovum pick-up procedures in superovulated cycles weekly since early 1989 with almost all procedures yielding more than one egg. With an egg available after ovum pick-up, fertilization leading to a cleaving (2- to 8-cell stage) embryo available for transfer occurred 60% of the time in unstimulated cycles. With multiple eggs available most of the time after superovulation IVF-ET, at least one cleaved embryo was transferred in 89% of these cases. With only 18 ET procedures completed after natural cycle IVF -ET, there was no demonstratable significant difference in the chances for ET after ovum pick-up (P = 0.098) compared with superovulation IVF-ET cases. A 60% overall fertilization rate per egg is also observed in our IVF -ET cycles done for tubal disease when superovulation is employed. These rates seem lower than the 85% to 100% fertilization rates per egg after unstimulated IVF -ET reported by others (4-7) but similar to fertilization rates reported by most IVF ET clinics after superovulation IVF-ET (13). A higher fertilization rate per egg after unstimulated IVF -ET might be expected because the single egg retrieved has matured before the LH stimulus, as opposed to a somewhat heterogeneous cohort of eggs aspirated from both small and large follicles after superovulation IVF-ET. However, fertilization rates of 60% even after an egg is aspirated in a natural IVF -ET cycle may be a realistic expectation for many IVF -ET laboratories. Pregnancy rates per ovum pick-up are higher at 19% for stimulated versus 5% for natural cycle IVF-ET (P = 0.044). These higher PRs per ovum pick-up for stimulated cycles would be expected because of the higher chance for eggs and embryos to be transferred after an ovum pick-up in superovulation IVF -ET cases. The two pregnancies in the 40 natural cycle ovum pick-up cases went to term with 48 of 65 superovulation IVF-ET pregnancies (26% early pregnancy loss) going to term after 338 ovum pick-up procedures. With only two natural cycle IVF -ET pregnancies, both going to term, there was no demonstratable difference in pregnancy loss rates between natural and superovulation IVF -ET. Pregnancy rates per ET procedure are similar after both natural (11 %) and superovulation IVF ET (22%) (P = 0.434) despite the fact that between one and four embryos (mean = 3) were transferred after superovulation IVF-ET. High luteal E 2 :P ratios have been implicated as a reason for lower than expected rates of implantation per embryo transferred after super ovulated IVF-ET (9). There was no difference between the E 2 :P ratios in the midluteal phase of natural cycle IVF -ET versus that observed after superovulation IVF-ET. In conclusion, Cancellation rates after the start of daily monitoring for natural cycle IVF -ET are very high. Significantly more natural cycle IVF -ET egg retrieval procedures end without retrieving an egg at all compared with superovulation IVF -ET. This leads to large numbers of expensive and unproductive procedure room and gamete laboratory preparations. In this protocol, natural cycle IVF ET was not found to be an efficient therapy for tubal infertility when compared with superovulation IVF -ET. REFERENCES 1. Edwards RG, Steptoe PC, Purdy JM. Establishing full term human pregnancies using cleaving embryos grown in vitro. Br J Obstet GynaecoI1980;87: Vol. 60, No.2, August 1993 Claman et al. Natural cycle versus superovulation IVF-ET 301

5 2. Fishel SB, Edwards RG, Purdy JM, Steptoe PC, Webster J, Walters E, et al. Implantation, abortion and birth after in vitro fertilization using the natural menstrual cycle or follicular stimulation with clomiphene citrate and human menopausal gonadotropin. J Vitro Fert Embryo Transfer 1985;2: Taymor ML, Seibel MM, Smith D, Levesue L. Ovulation timing by luteinizing hormone assay and follicle puncture. Obstet GynecoI1983;62: Foulot H, Ranoux C, Dubuisson J-B, Rambaud D, Aubriot F -X, Poirot C. In vitro fertilization without ovarian stimulation: a simplified protocol applied in 80 cycles. Fertil Steril 1989;52: Ramsewak SS, Cooke ID, Li T-C, Kumar A, Monks NJ, Lenton EA. Are factors that influence oocyte fertilization also predictive? An assessment of 148 cycles of in vitro fertilization without gonadotropin stimulation. Fertil Steril 1990;54: Paulson FJ, Sauer MV, Francis MM, Macaso TM, Lobo RA. In vitro fertilization in unstimulated cycles: the University of Southern California experience. Fertil Steril 1992;57: Taymor ML, Ranoux CJ, Gross GL. Natural oocyte retrieval with intravaginal fertilization: a simplified approach to in vitro fertilization. Obstet Gynecol 1992;80: World Health Organization. WHO Laboratory manual for the examination of human semen and semen-cervical mucus interaction. 2nd ed. Cambridge: The Press Syndicate of the University of Cambridge, Claman P, Domingo M, Leader A. Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone. Hum Reprod 1992;7: Tanphaichitr N, Agulnick A, Seibel MM, Taymor ML. Comparison of the in vitro fertilization rate by human sperm capacitated by multiple tube swim up and percoll gradient centrifugation. J Vitro Fert Embryo Transfer 1988;5: Ramsewak SS, Kumar A, Welsby R, Mowforth A, Lenton EA, Cooke ID. Is analgesia required for transvaginal single follicle aspiration in in vitro fertilization? A double blind study. J Vitro Fert Embryo Transfer 1990;7: Meldrum DR, Wisot A, Hamilton F, Gutlay AL, Kempton W, Huynh D. Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval. Fertil Steril 1989;51: Medical Research International, Society for Assisted Reproductive Technology, The American Fertility Society. In vitro fertilization-embryo transfer (lvf-et) in the United States: 1989 results from the IVF-ET Registry. Fertil Steril 1991;55: Claman et al. Natural cycle versus superovulation IVF-ET Fertility and Sterility

Utility of in vitro fertilization at diagnostic laparoscopy*

Utility of in vitro fertilization at diagnostic laparoscopy* FERTILITY AND STERILITY Copyright" 1994 The American Fertility Society Printed on acid-free paper in U. S. A. Utility of in vitro fertilization at diagnostic laparoscopy* Paul R. Gindoff, M.D.t Jerry L.

More information

Milan Reljič, Ph.D., Veljko Vlaisavljević, Ph.D., Vida Gavrić, M.Sc., Borut Kovačič, Ph.D.,

Milan Reljič, Ph.D., Veljko Vlaisavljević, Ph.D., Vida Gavrić, M.Sc., Borut Kovačič, Ph.D., FERTILITY AND STERILITY VOL. 75, NO. 3, MARCH 2001 Copyright 2001 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Value of the serum estradiol

More information

Bulent Urman, M.D.* Margo R. Fluker, M.D. Basil Ho Yuen, M.B., Ch.B.t

Bulent Urman, M.D.* Margo R. Fluker, M.D. Basil Ho Yuen, M.B., Ch.B.t FERTILITY AND STERILITY Copyright c 1992 The American Fertility Society Vol. 57, No.6, June 1992 Printed on acid-free paper in U.S.A. The outcome of in vitro fertilization and embryo transfer in women

More information

Department of Gynaecology and Reproductive Medicine, University Hospital, University of Western Ontario, London, Ontario, Canada

Department of Gynaecology and Reproductive Medicine, University Hospital, University of Western Ontario, London, Ontario, Canada FERTILITY AND STERILITY Copyright 1992 The American Fertility Society Printed on acid-free paper in U.S.A. Randomized, prospective comparison of luteal leuprolide acetate and gonadotropins versus clomiphene

More information

I. ART PROCEDURES. A. In Vitro Fertilization (IVF)

I. ART PROCEDURES. A. In Vitro Fertilization (IVF) DFW Fertility Associates ASSISTED REPRODUCTIVE TECHNOLOGY (ART) Welcome to DFW Fertility Associates/ Presbyterian-Harris Methodist Hospital ARTS program. This document provides an overview of treatment

More information

Timur Giirgan, M.D.* Bulent Urman, M.D. Hakan Yarali, M.D. Hakan E. Duran, M.D.

Timur Giirgan, M.D.* Bulent Urman, M.D. Hakan Yarali, M.D. Hakan E. Duran, M.D. FERTILITY AND STEFULI~ Vol. 68, No. 3, September 1997 Copyright 1997 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Published by Elsevier Science Inc. Follicle-stimulating

More information

Minimal stimulation using recombinant follicle-stimulating hormone and a gonadotropin-releasing hormone antagonist in women of advanced age

Minimal stimulation using recombinant follicle-stimulating hormone and a gonadotropin-releasing hormone antagonist in women of advanced age FERTILITY AND STERILITY VOL. 81, NO. 4, APRIL 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Minimal stimulation using recombinant

More information

Infertility treatment

Infertility treatment In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation

More information

Assisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi

Assisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi Assisted Reproduction By Dr. Afraa Mahjoob Al-Naddawi Learning Objectives: By the end of this lecture, you will be able to: 1) Define assisted reproductive techniques (ART). 2) List indications for various

More information

Female Reproductive System. Lesson 10

Female Reproductive System. Lesson 10 Female Reproductive System Lesson 10 Learning Goals 1. What are the five hormones involved in the female reproductive system? 2. Understand the four phases of the menstrual cycle. Human Reproductive System

More information

Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol

Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol Yamanashi Med. J. 14(3), 77 ~ 82, 1999 Original Article Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol Tsuyoshi KASAI and Kazuhiko

More information

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve

More information

Infertility. Review and Update Clifford C. Hayslip MD Intrauterine Inseminations

Infertility. Review and Update Clifford C. Hayslip MD Intrauterine Inseminations Infertility Review and Update Clifford C. Hayslip MD Intrauterine Inseminations Beneficial effects of IUI not consistently documented in studies No deleterious effects on fertility 3-4 cycles of IUI should

More information

Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary

Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary Subfertility Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary Infertility affects about 15 % of couples. age of the female. Other factors that

More information

Is it the seed or the soil? Arthur Leader, MD, FRCSC

Is it the seed or the soil? Arthur Leader, MD, FRCSC The Physiological Limits of Ovarian Stimulation Is it the seed or the soil? Arthur Leader, MD, FRCSC Objectives 1. To consider how ovarian stimulation protocols work in IVF 2. To review the key events

More information

Significance of basal follicle-stimulating hormone levels in women with one ovary in a program of in vitro fertilization*

Significance of basal follicle-stimulating hormone levels in women with one ovary in a program of in vitro fertilization* FERTILITY AND STERILITY Copyright e 1992 The American Fertility Society Printed on acid-free paper in U.S.A. Significance of basal follicle-stimulating hormone levels in women with one ovary in a program

More information

Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization and timing of embryo transfer

Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization and timing of embryo transfer FERTILITY AND STERILITY Copyright tl 1989 The American Fertility Society Printed on acid-free paper in U. S.A. Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization

More information

Prospective study of short and ultrashort regimens of gonadotropinreleasing hormone agonist in an in vitro fertilization program

Prospective study of short and ultrashort regimens of gonadotropinreleasing hormone agonist in an in vitro fertilization program FERTILITY AND STERILITY Copyright 1992 The American Fertility Society Printed on acid-free paper in U.S.A. Prospective study of short and ultrashort regimens of gonadotropinreleasing hormone agonist in

More information

Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? *

Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? * Middle East Fertility Society Journal Vol. 11, No. 2, 2006 Copyright Middle East Fertility Society Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? * Amany A.M. Shaltout, M.D. Mohamed

More information

Recent Developments in Infertility Treatment

Recent Developments in Infertility Treatment Recent Developments in Infertility Treatment John T. Queenan Jr., MD Professor, Dept. Of Ob/Gyn University of Rochester Medical Center Rochester, NY Disclosures I don t have financial interest or other

More information

Ovarian response in three consecutive in vitro fertilization cycles

Ovarian response in three consecutive in vitro fertilization cycles FERTILITY AND STERILITY VOL. 77, NO. 4, APRIL 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Ovarian response in

More information

IN VITRO FERTILIZATION

IN VITRO FERTILIZATION FERTILITY AND STERILITY VOL. 72, NO. 5, NOVEMBER 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. IN VITRO FERTILIZATION

More information

The predictive value of idiopathic failure to fertilize on the first in vitro fertilization attempt*

The predictive value of idiopathic failure to fertilize on the first in vitro fertilization attempt* FERTILITY AND STERILITY Copyright 1991 The American Fertility Society Printed on acid-free paper in U.S.A. The predictive value of idiopathic failure to fertilize on the first in vitro fertilization

More information

Reproductive Endocrinology & Infertility Glossary

Reproductive Endocrinology & Infertility Glossary Reproductive Endocrinology & Infertility Glossary The following is a glossary of terms you may hear during your association with the University of Mississippi Health Care's reproductive endocrinology and

More information

Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome

Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome FERTILITY AND STERILITY Copyright e 1993 The American Fertility Society Vol. 59, No.3, March 1993 Printed on acid-free paper in U.S.A. Gonadotropin-releasing hormone agonist reduces the miscarriage rate

More information

LOW RESPONDERS. Poor Ovarian Response, Por

LOW RESPONDERS. Poor Ovarian Response, Por LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients

More information

* Present address: Foothills Hospital, Calgary, Alberta, Canada.

* Present address: Foothills Hospital, Calgary, Alberta, Canada. FERTILITY AND STERILITY Copyright 1993 The American Fertility Society Vol. 59, No. 6, June 1993 Printed on acid-free paper in U.S.A. A randomized trial of in vitro fertilization versus conventional treatment

More information

Risk factors for spontaneous abortion in menotropintreated

Risk factors for spontaneous abortion in menotropintreated FERTILITY AND STERILITY Copyright ~ 1987 The American Fertility Society Vol. 48, No. 4, October 1987 Printed in U.S.A. Risk factors for spontaneous abortion in menotropintreated women Michael Bohrer, M.D.*

More information

10.7 The Reproductive Hormones

10.7 The Reproductive Hormones 10.7 The Reproductive Hormones December 10, 2013. Website survey?? QUESTION: Who is more complicated: men or women? The Female Reproductive System ovaries: produce gametes (eggs) produce estrogen (steroid

More information

Puerto Rico Fertility Center

Puerto Rico Fertility Center Puerto Rico Fertility Center General Information of the In-Vitro Fertilization Program Dr. Pedro J. Beauchamp First test-tube baby IN PUERTO RICO Dr. Pedro Beauchamp with Adlin Román in his arms. Paseo

More information

Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients

Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients International Reproductive Medicine Volume 2013, Article ID 135258, 4 pages http://dx.doi.org/10.1155/2013/135258 Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin

More information

K.W.Fuh, X.Wang, A.Tai, I.Wong and R.J.Norman 1

K.W.Fuh, X.Wang, A.Tai, I.Wong and R.J.Norman 1 Human Reproduction vol.12 no.10 pp.2162 2166, 1997 Intrauterine insemination: effect of the temporal relationship between the luteinizing hormone surge, human chorionic gonadotrophin administration and

More information

Luteal phase rescue after GnRHa triggering Progesterone and Estradiol

Luteal phase rescue after GnRHa triggering Progesterone and Estradiol Luteal phase rescue after GnRHa triggering Progesterone and Estradiol L. Engmann University of Connecticut Disclaimer Fertility Speaker Bureau Merck Pharmaceuticals Introduction GnRH agonist is effective

More information

LUTEINIZED UNRUPTURED FOLLICLE SYNDROME: A SUBTLE CAUSE OF INFERTILITY*

LUTEINIZED UNRUPTURED FOLLICLE SYNDROME: A SUBTLE CAUSE OF INFERTILITY* FERTILITY AND STERILITY Copyright c 1978 The American Fertility Society Vol. 29, No.3, March 1978 Printed in U.S.A. LUTEINIZED UNRUPTURED FOLLICLE SYNDROME: A SUBTLE CAUSE OF INFERTILITY* JAROSLA V MARIK,

More information

Embryo Selection after IVF

Embryo Selection after IVF Embryo Selection after IVF Embryo Selection after IVF Many of human embryos produced after in vitro fertilization carry abnormal chromosomes. Placing a chromosomally normal embryo (s) into a normal uterus

More information

Ovulation induction in women age 40 and older: the importance of basal follicle-stimulating hormone level and chronological age*

Ovulation induction in women age 40 and older: the importance of basal follicle-stimulating hormone level and chronological age* FERTILITY AND STERILITY Vol. 58, No.4, October 1992 Copyright It! 1992 The American Fertility Society Printed on acid-free paper in U. S.A. Ovulation induction in women age 40 and older: the importance

More information

Superovulation with human menopausal gonadotropins is associated with endometrial gland-stroma dyssynchrony*

Superovulation with human menopausal gonadotropins is associated with endometrial gland-stroma dyssynchrony* aes FERTILITY AND STERILITY Vol. 61, No.4, April 1994 Copyright ee) 1994 The American Fertility Society Printed on acid-free paper in U. S. A. r I Superovulation with human menopausal gonadotropins is

More information

Principles of Ovarian Stimulation

Principles of Ovarian Stimulation Principles of Ovarian Stimulation Dr Genia Rozen Gynaecologist and Fertility Specialist Royal Women s Hospital and Melbourne IVF Learning objectives Why ovarian stimulation Recap physiology Ovarian cycle

More information

The effects of prior gravidity on the outcomes of ovum donor and own oocyte cycles

The effects of prior gravidity on the outcomes of ovum donor and own oocyte cycles FERTILITY AND STERILITY Vol. 65, No.3, March 1996 Copyright t';, 1996 American Society for Reproductive Medicine Printed on acid-free paper in U. s. A. The effects of prior gravidity on the outcomes of

More information

In Vitro Fertilization What to expect

In Vitro Fertilization What to expect Patient Education In Vitro Fertilization What to expect This handout describes how to prepare for and what to expect when you have in vitro fertilization. It provides written information about this process,

More information

Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles

Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles Arch Gynecol Obstet (2010) 281:747 752 DOI 10.1007/s00404-009-1248-0 REPRODUCTIVE MEDICINE Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles Esra

More information

IVF Protocols: Hyper & Hypo-Responders, Implantation

IVF Protocols: Hyper & Hypo-Responders, Implantation IVF Protocols: Hyper & Hypo-Responders, Implantation Midwest Reproductive Symposium June 4-5, 4 2010 Subset : Hyper-Responders Mark R. Bush, MD, FACOG, FACS OBJECTIVE: Important goals for the PCOS patient

More information

Infertility Clinical Guideline

Infertility Clinical Guideline Infertility Clinical Guideline Ovarian Stimulation Guideline Purpose: To provide sufficient background regarding various ovarian stimulation protocols for In Vitro Fertilization cycles. Goal: To assist

More information

Effect of baseline ovarian cysts on in vitro fertilization and gamete intrafallopian transfer cycles*

Effect of baseline ovarian cysts on in vitro fertilization and gamete intrafallopian transfer cycles* FERTILITY AND STERILITY Copyright 1991 The American Fertility Society Printed on acid-free paper in U.S.A. Effect of baseline ovarian cysts on in vitro fertilization and gamete intrafallopian transfer

More information

Clomiphene-acetyl cysteine combination as a new protocol to a friendly IVF cycle

Clomiphene-acetyl cysteine combination as a new protocol to a friendly IVF cycle Middle East Fertility Society Journal Vol. 10, No. 2, 2005 Copyright Middle East Fertility Society Clomiphene-acetyl cysteine combination as a new protocol to a friendly IVF cycle Ahmed Y Rizk, M.D. *

More information

' ' ' ' ' ' ' ' COMPARISON BETWEEN HIGHLY PURIFIED--FSH AND HMG FOR SUPEROVULATION IN WOMEN UNDERGOING IN VITRO FERTILIZATION ORIGINAL RESEARCH

' ' ' ' ' ' ' ' COMPARISON BETWEEN HIGHLY PURIFIED--FSH AND HMG FOR SUPEROVULATION IN WOMEN UNDERGOING IN VITRO FERTILIZATION ORIGINAL RESEARCH ' ' ' ' ORIGINAL RESEARCH ' ' ' ' COMPARISON BETWEEN HIGHLY PURIFIED--FSH AND HMG FOR SUPEROVULATION IN WOMEN UNDERGOING IN VITRO FERTILIZATION Pierre Miron, MD, FRCSC, 1 Robert Casper, MD, FRCSC,2 Louise

More information

Prognostic value of day 3 estradiol on in vitro fertilization outcome*

Prognostic value of day 3 estradiol on in vitro fertilization outcome* FERTILITY AND STERILITY Vol. 64, No.6, December 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Prognostic value of day 3 estradiol on in vitro fertilization

More information

Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles

Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles Human Reproduction Vol.17, No.1 pp. 83 87, 2002 Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles Joseph E.Peña, Peter L.Chang 1, Lai-King Chan, Khaled

More information

Blastocyst-stage embryo transfer in patients who failed to conceive in three or more day 2 3 embryo transfer cycles: a prospective, randomized study

Blastocyst-stage embryo transfer in patients who failed to conceive in three or more day 2 3 embryo transfer cycles: a prospective, randomized study FERTILITY AND STERILITY VOL. 81, NO. 3, MARCH 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Blastocyst-stage embryo transfer

More information

Assisted Reproduction. Rajeevi Madankumar, 1,2 James Tsang, 1 Martin L. Lesser, 1 Daniel Kenigsberg, 1 and Steven Brenner 1 INTRODUCTION

Assisted Reproduction. Rajeevi Madankumar, 1,2 James Tsang, 1 Martin L. Lesser, 1 Daniel Kenigsberg, 1 and Steven Brenner 1 INTRODUCTION ( C 2005) DOI: 10.1007/s10815-005-4912-8 Assisted Reproduction Clomiphene citrate induced ovulation and intrauterine insemination: effect of timing of human chorionic gonadotropin injection in relation

More information

UW MEDICINE PATIENT EDUCATION. In Vitro Fertilization How to prepare and what to expect DRAFT

UW MEDICINE PATIENT EDUCATION. In Vitro Fertilization How to prepare and what to expect DRAFT UW MEDICINE PATIENT EDUCATION In Vitro Fertilization How to prepare and what to expect This handout tells how to prepare for and what to expect when you go through a cycle of in vitro fertilization. It

More information

New York Science Journal 2014;7(4)

New York Science Journal 2014;7(4) The Minimal Stimulation Protocol for ICSI: An Alternative Protocol for Ovarian Stimulation Adel Elsayed Ibrahim, MD Assisted Reproductive Unit Azhar University Adel.sayed29@gmail.com Abstract: Background:

More information

IVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)

IVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn) 34 11 Vol.34 No.11 2014 11 Nov. 2014 Reproduction & Contraception doi: 10.7669/j.issn.0253-3X.2014.11.0892 E-mail: randc_journal@163.com IVF ( 710003) : (H-hMG) - (IVF- ET) : GnRH H-hMG (H-hMG ) (rfsh

More information

Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles?

Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles? J Assist Reprod Genet (26) 23:427 431 DOI 1.17/s1815-6-965-x ASSISTED REPRODUCTION Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation

More information

Endocrinology of the Female Reproductive Axis

Endocrinology of the Female Reproductive Axis Endocrinology of the Female Reproductive Axis girlontheriver.com Geralyn Lambert-Messerlian, PhD, FACB Professor Women and Infants Hospital Alpert Medical School at Brown University Women & Infants BROWN

More information

Progesterone and clinical outcomes

Progesterone and clinical outcomes Synchronization of Slowly Developing Embryos Restores Implantation Success Richard T. Scott, Jr, MD, HCLD Clinical and Scientific Director, Reproductive Medicine Associates of New Jersey Professor and

More information

In Vitro Fertilization

In Vitro Fertilization Patient Education In Vitro Fertilization About the treatment This handout describes how to prepare for and what to expect when you have in vitro fertilization. It provides written information about this

More information

Utility of color Doppler indices of dominant follicular

Utility of color Doppler indices of dominant follicular Ultrasound Obstet Gynecol 2002; 20: 592 596 Utility of color Doppler indices of dominant follicular Blackwell Science, Ltd blood flow for prediction of clinical factors in in vitro fertilization-embryo

More information

Cigna Drug and Biologic Coverage Policy

Cigna Drug and Biologic Coverage Policy Cigna Drug and Biologic Coverage Policy Subject Infertility Injectables Table of Contents Coverage Policy... 1 General Background...16 Coding/Billing Information...20 References...20 Effective Date...

More information

Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M

Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Record Status This is a critical abstract of an economic

More information

Patient Information: Patient Name: Date of Birth:

Patient Information: Patient Name: Date of Birth: Weill Cornell Medicine Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine Informed Consent for Oocyte (Egg) Cryopreservation Patient Information: Part 1: I have requested to be treated

More information

in vitro fertilization

in vitro fertilization FERTILITY AND STERILITY VOL 69, NO. 6, JUNE 1998 Copyright (#1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Elevated levels of basal

More information

Fertility assessment and assisted conception

Fertility assessment and assisted conception Fertility assessment and assisted conception Dr Geetha Venkat MD FRCOG Director Pulse Learning Women s health 14 September 2016 Disclosure statement Dr Venkat is a director of Harley Street Fertility Clinic.

More information

AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE

AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Formerly The American Fertility Society OVULATION DETECTION A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive

More information

Sonographic determination of a possible adverse effect of domiphene citrate on endometrial growth

Sonographic determination of a possible adverse effect of domiphene citrate on endometrial growth Human Reproduction vol.5 no.6 pp.670-674, 1990 Sonographic determination of a possible adverse effect of domiphene citrate on endometrial growth Yael Gonen 1 and Robert F.Casper Division of Reproductive

More information

Infertility F REQUENTLY A SKED Q UESTIONS. Q: Is infertility a common problem?

Infertility F REQUENTLY A SKED Q UESTIONS. Q: Is infertility a common problem? Infertility (female factors). In another one third of cases, infertility is due to the man (male factors). The remaining cases are caused by a mixture of male and female factors or by unknown factors.

More information

The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study

The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study Clinical research The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study Ashraf Moini 1,2, Shahrzad Zadeh Modarress 3, Elham Amirchaghmaghi

More information

The Presence of Hydrosalpinx May Not Adversely Affect the Implantation and Pregnancy Rates in In Vitro Fertilization Treatment1

The Presence of Hydrosalpinx May Not Adversely Affect the Implantation and Pregnancy Rates in In Vitro Fertilization Treatment1 CLINICAL ASSISTED REPRODUCTION The Presence of Hydrosalpinx May Not Adversely Affect the Implantation and Pregnancy Rates in In Vitro Fertilization Treatment1 ERNEST HUNG-YU NG,2,3 WILLIAM SHU-BIU YEUNG,2

More information

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IVF WITH EMBRYO TRANSFER

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IVF WITH EMBRYO TRANSFER *40639* 40639 WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IVF WITH EMBRYO TRANSFER I have requested treatment by the physicians and (Print Patient s name) staff of the Women & Infants Fertility

More information

Acupuncture Treatment For Infertile Women Undergoing Intracytoplasmic Sperm injection

Acupuncture Treatment For Infertile Women Undergoing Intracytoplasmic Sperm injection Acupuncture Treatment For Infertile Women Undergoing Intracytoplasmic Sperm injection Sandra L. Emmons, MD Phillip Patton, MD Source: Medical Acupuncture, A Journal For Physicians By Physicians Spring

More information

Web Activity: Simulation Structures of the Female Reproductive System

Web Activity: Simulation Structures of the Female Reproductive System differentiate. The epididymis is a coiled tube found along the outer edge of the testis where the sperm mature. 3. Testosterone is a male sex hormone produced in the interstitial cells of the testes. It

More information

A novel ovarian stimulation protocol for use with the assisted reproductive technologies*

A novel ovarian stimulation protocol for use with the assisted reproductive technologies* FERTILITY AND STERILITY Vo!' 60, No.5, November 1993 Copyright 1993 The American Fertility Society Printed on acid-free paper in U. S. A. A novel ovarian protocol for use with the assisted reproductive

More information

Programming in vitro fertilization for a 5- or 3-day week

Programming in vitro fertilization for a 5- or 3-day week Ass~st.d.reproductive tec"no'ogy FERTILITY AND STERILITY Copyright I[J 1991 The American Fertility Society Printed on acid-free paper in U.S.A. Programming in vitro fertilization for a 5- or 3-day week

More information

Neil Goodman, MD, FACE

Neil Goodman, MD, FACE Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects

More information

Original Article. Fauzia HaqNawaz 1*, Saadia Virk 2, Tasleem Qadir 3, Saadia Imam 3, Javed Rizvi 2

Original Article. Fauzia HaqNawaz 1*, Saadia Virk 2, Tasleem Qadir 3, Saadia Imam 3, Javed Rizvi 2 Original Article Comparison of Letrozole and Clomiphene Citrate Efficacy along with Gonadotrophins in Controlled Ovarian Hyperstimulation for Intrauterine Insemination Cycles Fauzia HaqNawaz 1*, Saadia

More information

A controlled study of gonadotropin-releasing hormone agonist (buserelin acetate*) for folliculogenesis in routine in vitro fertilization patients

A controlled study of gonadotropin-releasing hormone agonist (buserelin acetate*) for folliculogenesis in routine in vitro fertilization patients FERTILITY AND STERILITY Copyright" 1991 The American Fertility Society Vol. 56, No. 3, September 1991 Printed on acid-free paper in U.S.A. A controlled study of gonadotropin-releasing hormone agonist (buserelin

More information

Clinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G.

Clinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G. UvA-DARE (Digital Academic Repository) Clinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G. Link to publication Citation for published version (APA): Al-Inany,

More information

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1.

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1. *40675* 40675 MR-838 (9-2017) WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1. I, and (Print Patient s name) (Print

More information

Prospective study of a modified gonadotropin-releasing hormone agonist long protocol in an in vitro fertilization program

Prospective study of a modified gonadotropin-releasing hormone agonist long protocol in an in vitro fertilization program FERTILITY AND STERILITY Copyright 1994 The American Fertility Society Printed on acid-free paper in U. s. A. Prospective study of a modified gonadotropin-releasing hormone agonist long protocol in an in

More information

Reproduction and Development. Female Reproductive System

Reproduction and Development. Female Reproductive System Reproduction and Development Female Reproductive System Outcomes 5. Identify the structures in the human female reproductive system and describe their functions. Ovaries, Fallopian tubes, Uterus, Endometrium,

More information

Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization

Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization Peter Kovacs, M.D., a Timea Kovats, M.D., a Artur Bernard,

More information

Is the fallopian tube better than the uterus? Evidence on intrauterine insemination versus fallopian sperm perfusion

Is the fallopian tube better than the uterus? Evidence on intrauterine insemination versus fallopian sperm perfusion F, V & V IN OBGYN, 2010, MONOGRAPH: 36-41 Artificial insemination Is the fallopian tube better than the uterus? Evidence on intrauterine insemination versus fallopian sperm perfusion Arne SUNDE 1, Jarl

More information

LUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi

LUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi LUTEAL PHASE SUPPORT Doç. Dr. Nafiye Yılmaz Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi TAJEV, 2014 1 ART & success *Live birth rate 2 Optimal luteal phase Etiology of luteal phase deficiency

More information

In Vitro Fertilization and Embryo Transfer

In Vitro Fertilization and Embryo Transfer Acta Medica et Biologica Vol. 41, No.4, 171-176, 1993 The Influence of Low Ovarian Response on the Results of In Vitro Fertilization and Embryo Transfer Hirofumi HIRASAWA Department of Obstetrics and Gynecology,

More information

Article Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles

Article Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles RBMOnline - Vol 13. No 3. 2006 326 330 Reproductive BioMedicine Online; www.rbmonline.com/article/1911 on web 13 June 2006 Article Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist

More information

Article Letrozole versus human menopausal gonadotrophin in women undergoing intrauterine insemination

Article Letrozole versus human menopausal gonadotrophin in women undergoing intrauterine insemination RBMOnline - Vol 13. No 2. 2006 208-212 Reproductive BioMedicine Online; www.rbmonline.com/article/2334 on web 30 May 2006 Article Letrozole versus human menopausal gonadotrophin in women undergoing intrauterine

More information

Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization embryo transfer

Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization embryo transfer Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization embryo transfer Mohamed F. Mitwally, M.D., H.C.L.D., a Michael P. Diamond,

More information

Effects of functional ovarian cysts detected on the 7th day of gonadotropin-releasing hormone analog administration on the outcome of IVF treatment

Effects of functional ovarian cysts detected on the 7th day of gonadotropin-releasing hormone analog administration on the outcome of IVF treatment FERTILITY AND STERILITY VOL. 74, NO. 5, NOVEMBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Effects of functional

More information

INDICATIONS OF IVF/ICSI

INDICATIONS OF IVF/ICSI PROCESS OF IVF/ICSI INDICATIONS OF IVF/ICSI IVF is most clearly indicated when infertility results from one or more causes having no other effective treatment; Tubal disease. In women with blocked fallopian

More information

Modified natural cycle IVF and mild IVF: a 10 year Swedish experience

Modified natural cycle IVF and mild IVF: a 10 year Swedish experience Reproductive BioMedicine Online (2010) 20, 156 162 www.sciencedirect.com www.rbmonline.com ARTICLE Modified natural cycle IVF and mild IVF: a 10 year Swedish experience Arthur Aanesen *, Karl-Gösta Nygren,

More information

Anti-Mullerian hormone (AMH) as predictor of ovarian reserve

Anti-Mullerian hormone (AMH) as predictor of ovarian reserve International Journal of Reproduction, Contraception, Obstetrics and Gynecology Shembekar CA et al. Int J Reprod Contracept Obstet Gynecol. 2017 Sep;6(9):4006-4010 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20174053

More information

Reproductive System. Testes. Accessory reproductive organs. gametogenesis hormones. Reproductive tract & Glands

Reproductive System. Testes. Accessory reproductive organs. gametogenesis hormones. Reproductive tract & Glands Reproductive System Testes gametogenesis hormones Accessory reproductive organs Reproductive tract & Glands transport gametes provide nourishment for gametes Hormonal regulation in men Hypothalamus - puberty

More information

Performance of patients with a ''frozen pelvis" in an in vitro fertilization program

Performance of patients with a ''frozen pelvis in an in vitro fertilization program FERTILITY AND STERILITY Copyright 1987 The American Fertility Society Printed in U.8A. Performance of patients with a ''frozen pelvis" in an in vitro fertilization program David Molloy, F.R.A.C.O.G.*t

More information

Causes of Infertility and Treatment Options

Causes of Infertility and Treatment Options Causes of Infertility and Treatment Options Dr Mrs.Kiran D. Sekhar Former vice President-FOGSI Former Chairperson- Genetics and Foetal medicine-fogsi Founder and Medical Director-Kiran Infertility centre

More information

Understanding Infertility, Evaluations, and Treatment Options

Understanding Infertility, Evaluations, and Treatment Options Understanding Infertility, Evaluations, and Treatment Options Arlene J. Morales, M.D., F.A.C.O.G. Fertility Specialists Medical Group, Inc. What We Will Cover Introduction What is infertility? Briefly

More information

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman IVM in PCOS patients Michael Grynberg René Frydman Department of Obstetrics and Gynecology A. Beclere Hospital, Clamart, France Maribor, Slovenia, 27-28 February 2009 Introduction (1) IVM could be a major

More information

Laboratoires Genevirer Menotrophin IU 1.8.2

Laboratoires Genevirer Menotrophin IU 1.8.2 Important missing information VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Infertility is when a woman cannot get pregnant (conceive) despite having regular unprotected sexual

More information

Department of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas

Department of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas FERTILITY AND STERILITY Copyright 1991 The American Fertility Society Vol. 56, No. 2, August 1991 Printed on ocid-free paper in U.S.A. Follicular size at the time of human chorionic gonadotropin administration

More information